ArticleO&G open2025
Evaluation of a Quality-Improvement Initiative to Address Nutritional Anemia in Gynecologic Oncology.
Article in O&G open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAnemia is common among patients with gynecologic cancers receiving systemic treatment and is associated with adverse outcomes. We describe a quality-improvement initiative designed to improve screening and treatment for nutritional causes of anemia in this population, and we assess the effect of this intervention on hemoglobin levels and blood transfusions.
methodsWe implemented a quality-improvement intervention that automatized regular laboratory evaluation for nutritional causes of anemia in patients with gynecologic malignancies receiving systemic treatment who had hemoglobin levels below 12 g/dL. Patients with nutritional deficiencies were treated with intravenous iron or oral vitamin B12. We evaluated the association of the intervention and change in hemoglobin levels over three cycles of treatment (delta hemoglobin), along with the rate of blood transfusion. Thirty patients with hemoglobin levels below 12 g/dL were administered a survey regarding anemia, fatigue, and the acceptability of the intervention.
resultsThe overall rates of iron and vitamin B12 deficiency were 54.2% and 8.1%, respectively. The control period included 117 patients, and the intervention period included 101 patients. Our quality-improvement process increased the rate of evaluation for iron and vitamin B12 deficiency in patients with anemia from 23.1% and 20.5%, respectively, to more than 90%. When controlling for relevant demographic and cancer-related characteristics, the delta hemoglobin was 0.45 g/dL higher in patients treated after the intervention when compared with patients treated before the intervention. In patients with hemoglobin levels below 11 g/dL, the delta hemoglobin was 0.91 g/dL higher after the intervention. There was no significant difference in the rate of blood transfusion. Patients with anemia who were surveyed were concerned about fatigue and overall accepting of the intervention.
conclusionUsing medical record treatment plans to send reflex anemia evaluation tests was effective at increasing rates of screening for nutritional deficiencies. Proactively addressing nutritional causes of anemia was associated with maintenance of higher hemoglobin levels in patients with gynecologic cancer receiving systemic treatment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.